Could be? Is. AA for breast cancer EOY. Plus bladder. Plus other indications. SGEN, more or less, is forking over 2b. VenBio said it was worth, if approved eoy, 1.5b. And that's only for breast cancer. Great data today on bladder. Roche recently got drug approved, but has way more adverse effects, including infertility.